Latest Articles
Cartherics wins APAC Award for most promising iPSC therapy pipeline - Biotech Dispatch
Cartherics wins APAC Award for most promising iPSC therapy pipeline Biotech Dispatch
Published: Sept. 11, 2025, 12:46 a.m.
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation - Rare Cancer News
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation Rare Cancer News
Published: Sept. 10, 2025, 12:49 p.m.
New Illinois law restricts the use of AI in psychotherapy - marketplace.org
New Illinois law restricts the use of AI in psychotherapy marketplace.org
Published: Sept. 2, 2025, 3:15 p.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED
Published: Sept. 2, 2025, 11:40 a.m.
Stem Cell Therapy: Revolutionizing Women’s Reproductive Health - BIOENGINEER.ORG
Stem Cell Therapy: Revolutionizing Women’s Reproductive Health BIOENGINEER.ORG
Published: Aug. 30, 2025, 7:33 a.m.
Menstrual blood-derived endometrial stem cells ameliorate neuroinflammation and apoptosis through JAK2/STAT3 signaling pathway in NPC1 mutant cell and mice - Stem Cell Research & Therapy
Menstrual blood-derived endometrial stem cells ameliorate neuroinflammation and apoptosis through JAK2/STAT3 signaling pathway in NPC1 mutant cell and mice Stem Cell Research & Therapy
Published: Aug. 29, 2025, 1:47 a.m.
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. - AInvest
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. AInvest
Published: Aug. 28, 2025, 8:24 a.m.
Rina-S Earns FDA Breakthrough Therapy Designation in Endometrial Cancer - CancerNetwork
Rina-S Earns FDA Breakthrough Therapy Designation in Endometrial Cancer CancerNetwork
Published: Aug. 26, 2025, 10:07 p.m.
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer - Targeted Oncology
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer Targeted Oncology
Published: Aug. 26, 2025, 6:30 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News
Published: Aug. 26, 2025, 6:04 p.m.
Link copied to clipboard!